Patent · US Active

Delivery particle

US8357649B2 · kind B2 · utility

10Cited by
34References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 4, 2010
Grant dateJan 22, 2013
Priority date
Expiry dateApr 2, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC11D2111/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application relates to benefit agent delivery compositions comprising a material selected from the group consisting of agglomerates comprising chelant and an encapsulated benefit agent; agglomerates comprising an encapsulated benefit agent having a shell comprising chelant; agglomerates comprising an encapsulated benefit agent having a core comprising chelant and combinations thereof, and processes for making and using such benefit agent delivery compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.